keyword
https://read.qxmd.com/read/38543820/acalculous-cholecystitis-in-covid-19-patients-a-narrative-review
#21
REVIEW
Evanthia Thomaidou, Eleni Karlafti, Matthaios Didagelos, Kalliopi Megari, Eleni Argiriadou, Karolina Akinosoglou, Daniel Paramythiotis, Christos Savopoulos
Acute acalculous cholecystitis (AAC) represents cholecystitis without gallstones, occurring in approximately 5-10% of all cases of acute cholecystitis in adults. Several risk factors have been recognized, while infectious diseases can be a cause of cholecystitis in otherwise healthy people. Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has spread worldwide, leading to an unprecedented pandemic. The virus enters cells through the binding of the spike protein to angiotensin-converting enzyme 2 (ACE2) receptors expressed in many human tissues, including the epithelial cells of the gastrointestinal (GI) tract, and this explains the symptoms emanating from the digestive system...
March 15, 2024: Viruses
https://read.qxmd.com/read/38543635/the-renin-angiotensin-system-ras-in-covid-19-disease-where-we-are-3-years-after-the-beginning-of-the-pandemic
#22
REVIEW
Marco Prato, Natalia Tiberti, Cristina Mazzi, Federico Gobbi, Chiara Piubelli, Silvia Stefania Longoni
The RAS is a hormonal system playing a pivotal role in the control of blood pressure and electrolyte homeostasis, the alteration of which is associated with different pathologies, including acute respiratory distress syndrome (ARDS). As such, it is not surprising that a number of studies have attempted to elucidate the role and balance of the renin-angiotensin system (RAS) in COVID-19. In this review article, we will describe the evidence collected regarding the two main enzymes of the RAS (i.e., ACE and ACE2) and their principal molecular products (i...
March 14, 2024: Microorganisms
https://read.qxmd.com/read/38535093/cardiopulmonary-exercise-testing-in-heart-failure
#23
REVIEW
Michel Juarez, Cristian Castillo-Rodriguez, Dina Soliman, Gaspar Del Rio-Pertuz, Kenneth Nugent
Cardiopulmonary exercise testing (CPET) provides important information for the assessment and management of patients with heart failure. This testing measures the respiratory and cardiac responses to exercise and allows measurement of the oxygen uptake (V˙O2 ) max and the relationship between minute ventilation (V˙E) and carbon dioxide excretion (V˙CO2 ). These two parameters help classify patients into categories that help predict prognosis, and patients with a V˙O2 < 14 mL/kg/min and V˙E/V˙CO2 slope >35 have a poor prognosis...
February 20, 2024: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/38524936/biomarkers-and-signaling-pathways-of-diabetic-nephropathy-and-peripheral-neuropathy-possible-therapeutic-intervention-of-rutin-and-quercetin
#24
REVIEW
Tamsheel Fatima Roohi, Seema Mehdi, Sadaf Aarfi, K L Krishna, Suman Pathak, Seikh Mohammad Suhail, Syed Faizan
Diabetic nephropathy and peripheral neuropathy are the two main complications of chronic diabetes that contribute to high morbidity and mortality. These conditions are characterized by the dysregulation of multiple molecular signaling pathways and the presence of specific biomarkers such as inflammatory cytokines, indicators of oxidative stress, and components of the renin-angiotensin system. In this review, we systematically collected and collated the relevant information from MEDLINE, EMBASE, ELSEVIER, PUBMED, GOOGLE, WEB OF SCIENCE, and SCOPUS databases...
April 2024: Diabetology International
https://read.qxmd.com/read/38524336/manifestations-of-coronavirus-infection-disease-19-in-anterior-eye-segment-an-up-to-date-review
#25
REVIEW
Basheer Abdullah Marzoog
Coronavirus infection disease-19 (COVID-19) is a worldwide catastrophic emergency that first appeared in late 2019, in Wuhan, China. COVID-19 is a multitropism disease that first affects lung tissue. However, extrapulmonary manifestations have been suspected from the first COVID-19 cases. The ocular signs and symptoms were from the early changes that occur during the course of the disease. Changes in the anterior eye segment have a relatively higher incidence than the posterior eye segment. Of which, conjunctivitis, COVID-19 pharyngioceratoconjuctivitis, iridocyclitis, corneal punctate epitheliopathy, and pathomorphological changes in the physio-anatomy of the anterior eye segment...
2024: Oman Journal of Ophthalmology
https://read.qxmd.com/read/38516472/nephrological-detrimental-impacts-resulting-from-novel-immunotherapy-drugs-used-in-the-treatment-of-cancer-a-systematic-review
#26
REVIEW
Amisha Jaiswal, Kainaat Shergill, Kusalik Boppana, Naiela E Almansouri, Saloni Bakkannavar, Youmna Faheem, Tuheen Sankar Nath
The most recent advancements in cancer therapy center on efficiently and conveniently enhancing a patient's natural immune system. Immune checkpoint inhibitors (ICIs) are antibodies that target cytotoxic thymus (T) lymphocyte antigen-4 (CTLA-4) and its receptor. They function by stimulating T-cell activity against malignancies. Immune-related adverse events (irAEs) are a distinct class of inflammatory side effects that are specific to a given organ. Antineoplastic medications can impact any part of the kidney, leading to the development of proteinuria, hypertension, electrolyte abnormalities, glomerulonephritis, and both acute and chronic interstitial nephritis...
February 2024: Curēus
https://read.qxmd.com/read/38516430/efficacy-of-angiotensin-receptor-neprilysin-inhibitor-and-its-renal-outcome-in-heart-failure-patients-a-systematic-review-of-randomized-clinical-trials
#27
REVIEW
Naiela E Almansouri, Saloni Bakkannavar, Youmna Faheem, Amisha Jaiswal, Kainaat Shergill, Kusalik Boppana, Tuheen Sankar Nath
Heart failure (HF) is a major cause of morbidity and mortality and imposes a significant financial burden on healthcare systems globally. Angiotensin receptor-neprilysin inhibitor (ARNI), a novel neuroendocrine inhibitor, is frequently used in treating HF. However, there is still limited understanding regarding how it compares to other neuroendocrine inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs). The purpose of this research is to present the most recent data regarding the efficacy and renal impact of ARNIs in the treatment of HF in comparison to ACE inhibitors and ARBs...
February 2024: Curēus
https://read.qxmd.com/read/38496070/a-comparative-study-of-the-safety-and-efficacy-between-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-on-the-management-of-hypertension-a-systematic-review
#28
REVIEW
Tariladei S Peresuodei, Abhishek Gill, Chijioke Orji, Maiss Reghefaoui, Michell Susan Saavedra Palacios, Tuheen Sankar Nath
Renin-angiotensin-aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are commonly used in the management of hypertension. High blood pressure is a vital risk factor for cardiovascular disease. This study aims to establish any significant difference in using ACEIs and ARBs in managing hypertension. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to conduct this systematic review...
February 2024: Curēus
https://read.qxmd.com/read/38492325/role-of-angiotensin-ii-in-non-alcoholic-steatosis-development
#29
REVIEW
Zimri Aziel Alvarado-Ojeda, Celeste Trejo-Moreno, Eduardo Ferat-Osorio, Marisol Méndez-Martínez, Gladis Fragoso, Gabriela Rosas-Salgado
Fatty liver is a multifactorial disease characterized by excessive accumulation of lipids in hepatocytes (steatosis), insulin resistance, oxidative stress, and inflammation. This disease has a major public health impact because it is the first stage of a chronic and degenerative process in the liver that can lead to steatohepatitis, cirrhosis, and liver cancer. Although this disease is mainly diagnosed in patients with obesity, type 2 diabetes mellitus, and dyslipidemia, recent evidence indicates that vasoactive hormones such as angiotensin II (ANGII) not only promote endothelial dysfunction (ED) and hypertension, but also cause fatty liver, increase adipose tissue, and develop a pro-steatotic environment characterized by a low-grade systemic pro-inflammatory and pro-oxidant state, with elevated blood lipid levels...
March 15, 2024: Archives of Medical Research
https://read.qxmd.com/read/38485150/b-cells-in-pulmonary-arterial-hypertension-friend-foe-or-bystander
#30
REVIEW
Sébastien Sanges, Wen Tian, Sylvain Dubucquoi, Jason L Chang, Aurore Collet, David Launay, Mark R Nicolls
There is an unmet need for new therapeutic strategies that target alternative pathways to improve the prognosis of patients with pulmonary arterial hypertension (PAH). As immunity has been involved in the development and progression of vascular lesions in PAH, we review the potential contribution of B cells in its pathogenesis and evaluate the relevance of B cell-targeted therapies. Circulating B cell homeostasis is altered in PAH patients, with total B-cell lymphopenia, abnormal subset distribution (expansion of naïve and antibody-secreting cells, reduction of memory B cells) and chronic activation...
March 14, 2024: European Respiratory Journal
https://read.qxmd.com/read/38465214/ginseng-and-ginsenosides-on-cardiovascular-and-pulmonary-diseases-pharmacological-potentials-for-the-coronavirus-covid-19
#31
REVIEW
Ajay Vijayakumar, Jong-Hoon Kim
Since its outbreak in late 2019, the Coronavirus disease 2019 (COVID-19) pandemic has profoundly caused global morbidity and deaths. The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has major complications in cardiovascular and pulmonary system. The increased rate of mortality is due to delayed detection of certain biomarkers that are crucial in the development of disease. Furthermore, certain proteins and enzymes in cellular signaling pathways play an important role in replication of SARS-CoV-2...
March 2024: Journal of Ginseng Research
https://read.qxmd.com/read/38454417/active-plasma-renin-concentration-throughout-healthy-and-complicated-pregnancy-a-systematic-review-and-meta-analysis
#32
REVIEW
Wisal El Fathi, Maaike van Ochten, Munieb Rehman, Sander M J van Kuijk, Joanna IntHout, Chahinda Ghossein-Doha, Sander de Haas, Marc E A Spaanderman, Joris van Drongelen
BACKGROUND: Pregnancy is characterized by profound circulatory changes and compensatory adjustments in the renin-angiotensin-aldosterone system (RAAS). Differences in regulatory response may antedate or accompany vascular complicated pregnancy. We performed a systematic review and meta-analysis to delineate the trajectory of active plasma renin concentration (APRC) in healthy pregnancy and compare this to complicated pregnancy. METHODS: We performed a systematic review and meta-analysis on APRC during normotensive and hypertensive pregnancies, using PubMed (NCBI) and Embase (Ovid) databases...
March 7, 2024: Reproductive Biology and Endocrinology: RB&E
https://read.qxmd.com/read/38448689/managing-hyperkalemia-in-patients-with-heart-failure-on-guideline-directed-medical-therapy-challenges-and-opportunities
#33
JOURNAL ARTICLE
Giorgio Gentile, Jahid Hossain, Erberto Carluccio, Gianpaolo Reboldi
Heart failure is a chronic and invalidating syndrome that affects tens of millions of people worldwide with significant socio-economic ramifications for the health care systems. Significant progress in the understanding of the pathophysiology of heart failure has allowed the gradual introduction of several drug classes for the management of such patients. Beta-blockers, mineralocorticoid receptor antagonists, angiotensin receptor neprilysin inhibitors, and sodium-glucose-cotransporter 2 inhibitors are all considered pillars of the guideline-directed medical therapy for heart failure...
March 7, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38427969/comparative-effectiveness-of-sacubitril-valsartan-versus-angiotensin-receptor-blockers-in-patients-with-heart-failure-with-preserved-ejection-fraction-a-real-world-study
#34
JOURNAL ARTICLE
Munaza Riaz, Steven M Smith, Eric A Dietrich, David E Winchester, Jingchuan Guo, Haesuk Park
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Sacubitril/valsartan (SAC/VAL) or angiotensin receptor blockers (ARBs) are recommended therapy for heart failure with preserved ejection fraction (HFpEF), but little is known about their real-world comparative effectiveness among patients with HFpEF...
March 1, 2024: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/38426347/mineralocorticoid-receptors-in-vascular-smooth-muscle-blood-pressure-and-beyond
#35
REVIEW
Nicholas D Camarda, Jaime Ibarrola, Lauren A Biwer, Iris Z Jaffe
After half a century of evidence suggesting the existence of mineralocorticoid receptors (MR) in the vasculature, the advent of technology to specifically knockout the MR from smooth muscle cells (SMCs) in mice has elucidated contributions of SMC-MR to cardiovascular function and disease, independent of the kidney. This review summarizes the latest understanding of the molecular mechanisms by which SMC-MR contributes to (1) regulation of vasomotor function and blood pressure to contribute to systemic and pulmonary hypertension; (2) vascular remodeling in response to hypertension, vascular injury, obesity, and aging, and the impact on vascular calcification; and (3) cardiovascular pathologies including aortic aneurysm, heart valve dysfunction, and heart failure...
March 1, 2024: Hypertension
https://read.qxmd.com/read/38425757/recent-advances-in-the-treatment-and-delivery-system-of-diabetic-retinopathy
#36
REVIEW
Zhiyi Wang, Ningzhi Zhang, Pei Lin, Yiqiao Xing, Ning Yang
Diabetic retinopathy (DR) is a highly tissue-specific neurovascular complication of type 1 and type 2 diabetes mellitus and is among the leading causes of blindness worldwide. Pathophysiological changes in DR encompass neurodegeneration, inflammation, and oxidative stress. Current treatments for DR, including anti-vascular endothelial growth factor, steroids, laser photocoagulation, and vitrectomy have limitations and adverse reactions, necessitating the exploration of novel treatment strategies. This review aims to summarize the current pathophysiology, therapeutic approaches, and available drug-delivery methods for treating DR, and discuss their respective development potentials...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38420829/trim6-promotes-ros-mediated-inflammasome-activation-and-pyroptosis-in-renal-tubular-epithelial-cells-via-ubiquitination-and-degradation-of-gpx3-protein
#37
JOURNAL ARTICLE
Lin Liao, Pengyu Tao, Qiming Xu, Wenhao Chen, Jie Chen, Weiwei Liu, Wenrui Liu, Jing Hu, Jianrao Lu
BACKGROUND: Pyroptosis is a critical form of cell death during the development of chronic kidney disease (CKD). Tripartite motif 6 (TRIM6) is an E3-ubiquitin ligase that participates in the progression renal fibrosis (RF). The aim of this study was to investigate the roles of TRIM6 and Glutathione peroxidase 3 (GPX3) in oxidative stress-induced inflammasome activation and pyroptosis in Ang-II treated renal tubular epithelial cells. METHODS: To study its role in RF, TRIM6 expression was either reduced or increased in human kidney-2 (HK2) cells using lentivirus, and Ang-II, NAC and BMS-986299 were served as reactive oxygen species (ROS) inducer, ROS scavenger and NLRP3 agonist respectively...
February 5, 2024: Frontiers in Bioscience (Landmark Edition)
https://read.qxmd.com/read/38399561/refractory-iga-nephropathy-a-challenge-for-future-nephrologists
#38
JOURNAL ARTICLE
Vincenzo Di Leo, Francesca Annese, Federica Papadia, Maria Serena Russo, Marica Giliberti, Fabio Sallustio, Loreto Gesualdo
IgA nephropathy (IgAN) represents the most prevalent form of primary glomerulonephritis, and, on a global scale, it ranks among the leading culprits behind end-stage kidney disease (ESKD). Presently, the primary strategy for managing IgAN revolves around optimizing blood pressure and mitigating proteinuria. This is achieved through the utilization of renin-angiotensin system (RAS) inhibitors, namely, angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs). As outlined by the KDIGO guidelines, individuals who continue to show a persistent high risk of progressive ESKD, even with comprehensive supportive care, are candidates for glucocorticoid therapy...
February 5, 2024: Medicina
https://read.qxmd.com/read/38397857/novel-insights-into-the-cardioprotective-effects-of-the-peptides-of-the-counter-regulatory-renin-angiotensin-system
#39
REVIEW
Janette Alejandra Gamiño-Gutiérrez, Ivana María Terán-Hernández, Jairo Castellar-Lopez, Wendy Villamizar-Villamizar, Estefanie Osorio-Llanes, Mariali Palacios-Cruz, Wendy Rosales, Aileen Y Chang, Luis Antonio Díaz-Ariza, María Clara Ospino, Evelyn Mendoza-Torres
Currently, cardiovascular diseases are a major contributor to morbidity and mortality worldwide, having a significant negative impact on both the economy and public health. The renin-angiotensin system contributes to a high spectrum of cardiovascular disorders and is essential for maintaining normal cardiovascular homeostasis. Overactivation of the classical renin-angiotensin system is one of the most important pathophysiological mechanisms in the progression of cardiovascular diseases. The counter-regulatory renin-angiotensin system is an alternate pathway which favors the synthesis of different peptides, including Angiotensin-(1-7), Angiotensin-(1-9), and Alamandine...
January 23, 2024: Biomedicines
https://read.qxmd.com/read/38397773/sars-cov-2-spike-protein-stimulates-macropinocytosis-in-murine-and-human-macrophages-via-pkc-nadph-oxidase-signaling
#40
JOURNAL ARTICLE
WonMo Ahn, Faith N Burnett, Ajay Pandey, Pushpankur Ghoshal, Bhupesh Singla, Abigayle B Simon, Cassandra C Derella, Stephen A Addo, Ryan A Harris, Rudolf Lucas, Gábor Csányi
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While recent studies have demonstrated that SARS-CoV-2 may enter kidney and colon epithelial cells by inducing receptor-independent macropinocytosis, it remains unknown whether this process also occurs in cell types directly relevant to SARS-CoV-2-associated lung pneumonia, such as alveolar epithelial cells and macrophages. The goal of our study was to investigate the ability of SARS-CoV-2 spike protein subunits to stimulate macropinocytosis in human alveolar epithelial cells and primary human and murine macrophages...
January 30, 2024: Antioxidants (Basel, Switzerland)
keyword
keyword
91279
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.